Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

A cost-effectiveness analysis of a chemoresponse assay for treatment of patients with recurrent epithelial ovarian cancer.

Plamadeala V, Kelley JL, Chan JK, Krivak TC, Gabrin MJ, Brower SL, Powell MA, Rutherford TJ, Coleman RL.

Gynecol Oncol. 2014 Nov 25. pii: S0090-8258(14)01484-X. doi: 10.1016/j.ygyno.2014.11.019. [Epub ahead of print]

PMID:
25462203
[PubMed - as supplied by publisher]
Free Article
2.

Ovarian cancer in the United States: Contemporary patterns of care associated with improved survival.

Cliby WA, Powell MA, Al-Hammadi N, Chen L, Philip Miller J, Roland PY, Mutch DG, Bristow RE.

Gynecol Oncol. 2014 Oct 29. pii: S0090-8258(14)01407-3. doi: 10.1016/j.ygyno.2014.10.023. [Epub ahead of print]

PMID:
25449311
[PubMed - as supplied by publisher]
3.

Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Stage IV Uterine Serous Carcinoma.

Wilkinson-Ryan I, Frolova AI, Liu J, Stewart Massad L, Thaker PH, Powell MA, Mutch DG, Hagemann AR.

Int J Gynecol Cancer. 2015 Jan;25(1):63-68.

PMID:
25365590
[PubMed - as supplied by publisher]
4.

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.

Berton-Rigaud D, Devouassoux-Shisheboran M, Ledermann JA, Leitao MM, Powell MA, Poveda A, Beale P, Glasspool RM, Creutzberg CL, Harter P, Kim JW, Reed NS, Ray-Coquard I.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S55-60. doi: 10.1097/IGC.0000000000000228.

PMID:
25341582
[PubMed - in process]
5.

Recent advances in the treatment of sarcomas in gynecology.

Lange SS, Novetsky AP, Powell MA.

Discov Med. 2014 Sep;18(98):133-40.

PMID:
25227754
[PubMed - in process]
Free Article
6.

Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma.

Amant F, Floquet A, Friedlander M, Kristensen G, Mahner S, Nam EJ, Powell MA, Ray-Coquard I, Siddiqui N, Sykes P, Westermann AM, Seddon B.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S67-72. doi: 10.1097/IGC.0000000000000205.

PMID:
25033257
[PubMed - in process]
7.

A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.

Powell MA, Sill MW, Goodfellow PJ, Benbrook DM, Lankes HA, Leslie KK, Jeske Y, Mannel RS, Spillman MA, Lee PS, Hoffman JS, McMeekin DS, Pollock PM.

Gynecol Oncol. 2014 Oct;135(1):38-43. doi: 10.1016/j.ygyno.2014.07.083. Epub 2014 Jul 11.

PMID:
25019571
[PubMed - in process]
8.

A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients.

Novetsky AP, Zighelboim I, Guntupalli SR, Ioffe YJ, Kizer NT, Hagemann AR, Powell MA, Thaker PH, Mutch DG, Massad LS.

Gynecol Oncol. 2014 Aug;134(2):233-7. doi: 10.1016/j.ygyno.2014.06.012. Epub 2014 Jun 18.

PMID:
24952366
[PubMed - indexed for MEDLINE]
9.

Etiology and workup of fevers in gynecologic oncology patients.

McCartney SA, Sabo MC, Massad LS, Hagemann AR, Mutch DG, Powell MA, Thaker PH, Novetsky AP.

Int J Gynecol Cancer. 2014 Jun;24(5):950-5. doi: 10.1097/IGC.0000000000000129.

PMID:
24819658
[PubMed - in process]
10.

Postradiation damage to the pelvic girdle in cervical cancer patients: is intensity-modulated radiation therapy safer than conventional radiation?

Ioffe YJ, Hillen TJ, Zhou G, Schwarz JK, Massad LS, Powell MA, Hagemann AR, Mutch DG, Thaker PH.

Int J Gynecol Cancer. 2014 May;24(4):806-12. doi: 10.1097/IGC.0000000000000117.

PMID:
24670967
[PubMed - in process]
11.

Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer.

Garg G, Vangveravong S, Zeng C, Collins L, Hornick M, Hashim Y, Piwnica-Worms D, Powell MA, Mutch DG, Mach RH, Hawkins WG, Spitzer D.

Mol Cancer. 2014 Mar 7;13:50. doi: 10.1186/1476-4598-13-50.

PMID:
24602489
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.

Garg G, Yee C, Schwartz K, Mutch DG, Morris RT, Powell MA.

Gynecol Oncol. 2014 May;133(2):242-9. doi: 10.1016/j.ygyno.2014.02.021. Epub 2014 Feb 19.

PMID:
24561247
[PubMed - indexed for MEDLINE]
13.

Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3.

Garg G, Gibbs J, Belt B, Powell MA, Mutch DG, Goedegebuure P, Collins L, Piwnica-Worms D, Hawkins WG, Spitzer D.

BMC Cancer. 2014 Jan 21;14:35. doi: 10.1186/1471-2407-14-35.

PMID:
24447304
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Ovarian cancer, version 2.2013.

Morgan RJ Jr, Alvarez RD, Armstrong DK, Burger RA, Chen LM, Copeland L, Crispens MA, Gershenson DM, Gray HJ, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O'Malley DM, Penson RT, Powell MA, Remmenga SW, Sabbatini P, Santoso JT, Schink JC, Teng N, Werner TL, Dwyer MA, Hughes M; National comprehensive cancer networks.

J Natl Compr Canc Netw. 2013 Oct 1;11(10):1199-209.

PMID:
24142821
[PubMed - indexed for MEDLINE]
15.

Disclosing a diagnosis of cancer: considerations specific to gynecologic oncology patients.

Kuroki LM, Zhao Q, Jeffe DB, Powell MA, Hagemann AR, Thaker PH, Massad LS, Mutch DG, Zighelboim I.

Obstet Gynecol. 2013 Nov;122(5):1033-9. doi: 10.1097/AOG.0b013e3182a9bf42.

PMID:
24104784
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer.

Hagemann AR, Novetsky AP, Zighelboim I, Gao F, Massad LS, Thaker PH, Powell MA, Mutch DG, Wright JD.

Gynecol Oncol. 2013 Dec;131(3):535-40. doi: 10.1016/j.ygyno.2013.09.032. Epub 2013 Oct 4.

PMID:
24096113
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Management of sarcomas of the uterus.

Novetsky AP, Powell MA.

Curr Opin Oncol. 2013 Sep;25(5):546-52. doi: 10.1097/CCO.0b013e328363e0ef. Review.

PMID:
23942299
[PubMed - indexed for MEDLINE]
18.

Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.

Novetsky AP, Smith K, Babb SA, Jeffe DB, Hagemann AR, Thaker PH, Powell MA, Mutch DG, Massad LS, Zighelboim I.

Int J Gynecol Cancer. 2013 Jul;23(6):1016-21. doi: 10.1097/IGC.0b013e3182994365.

PMID:
23748176
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies.

Alvarez RD, Gray HJ, Timmins PF 3rd, Gibb RK, Edelson M, Fowler JM, Havrilesky LJ, McCauley DL, Nash JD, Rahaman J, Rash JK, Rodabaugh KJ, Powell MA, Bristow RE, Brown JV, Tewari D, Cliby WA, Anastasia P, Robinson WR 3rd, Shahin MS, Cantrell LA, Cloven NG, Gold MA, Hope JM, Muntz HG, Sorosky JI, Elkas JC, Frumovitz MM, Jewell E, Spillman MA, Naumann RW.

Gynecol Oncol. 2013 Apr;129(1):3-4. No abstract available.

PMID:
23638463
[PubMed - indexed for MEDLINE]
20.

Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.

Zighelboim I, Wright JD, Gao F, Case AS, Massad LS, Mutch DG, Powell MA, Thaker PH, Eisenhauer EL, Cohn DE, Valea FA, Alvarez Secord A, Lippmann LT, Dehdashti F, Rader JS.

Gynecol Oncol. 2013 Jul;130(1):64-8. doi: 10.1016/j.ygyno.2013.04.009. Epub 2013 Apr 13.

PMID:
23591400
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk